Ocugen IncChange company Symbol lookupSelect an option...OCGN Ocugen IncSMBK SmartFinancial IncSTAF Staffing 360 Solutions IncTEL TE Connectivity LtdBOKF BOK Financial CorpPRAA PRA Group IncFHN First Horizon Corp (Tennessee)XEL Xcel Energy IncXEC Cimarex Energy CoXCUR Exicure IncGo
Change company Symbol lookup
Select an option...
OCGN Ocugen Inc
SMBK SmartFinancial Inc
STAF Staffing 360 Solutions Inc
TEL TE Connectivity Ltd
BOKF BOK Financial Corp
PRAA PRA Group Inc
FHN First Horizon Corp (Tennessee)
XEL Xcel Energy Inc
XEC Cimarex Energy Co
XCUR Exicure Inc
Health Care : Biotechnology | Small Cap Value
Company profileOcugen, Inc., formerly Histogenics Corporation is a clinical stage biopharmaceutical company focused on discovering, developing and commercializing a pipeline of therapies for eye diseases. The Company offers a diversified ophthalmology portfolio that includes gene therapies, biologics, and small molecules and targets a range of retinal and ocular surface diseases. The Company is leveraging its modifier gene therapy platform to address genetically diverse inherited retinal disorders and dry age-related macular degeneration (AMD), based on nuclear hormone receptor genes NR2E3 (OCU400) and RORA (OCU410), respectively. The Company is also developing biologic therapies for wet-AMD, diabetic macular edema (DME) and diabetic retinopathy (OCU200), as well as for retinitis pigmentosa (OCU100).
|
|
|
|
| |
| Latest Earnings Met Consensus (Q4 ending 12/2020) | Next Earnings Announcement | ||||
|---|---|---|---|---|---|
| Q4 Non-GAAP earnings GAAP vs. Non-GAAP EarningsTD Ameritrade displays two types of stock earnings numbers, which are calculated differently and may report different values for the same period. GAAP earnings are the official numbers reported by a company, and non-GAAP earnings are adjusted to be more readable in earnings history and forecasts. Announced March 18, 2021 | -$0.03 | Q4 Estimate range of 4 analysts | -$0.02 to -$0.02 | Q1 Earnings will announce | (Unconfirmed) May 6, 2021 |
Quarterly Earnings History and Estimates
Show high-low estimates
Draw trendlines
Draw up to 3 lines inside the chart.
OCGN's fiscal year ends in December
Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.
Information provided by Copyright © 2021. All rights reserved.
Reuters content is the intellectual property of Reuters. Any copying, republication or redistribution of Reuters content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Reuters. Reuters is not liable for any errors or delays in content, or for any actions taken in reliance on any content. Reuters, Reuters Logo and the Sphere Logo are trademarks and registered trademarks of the Reuters Group of companies around the world.
Data is provided for information purposes only and is not intended for trading purposes. Reuters shall not be liable for any errors or delay in the content, or for any action taken in reliance on any content. The RIC or Reuters Instrument Code set has been developed and maintained by Reuters and is the intellectual property of Reuters.